Squarepoint Ops LLC
- SEC CIK
- 0001642575
- Latest filing
- Aug 14, 2026
JANX holding history
Janux Therapeutics, Inc. in every 13F filed by Squarepoint Ops LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
JANX overviewAll 13F holders of JANXFull Q2 2026 holdings
- Shares (Q2 2026)
- 532,321
- Value
- $8.18M
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 532,321 | $8.18M | <0.1% | −71,679−11.9% | Reduced | Holders |
| Q1 2026 | 604,000 | $8.40M | <0.1% | +213,048+54.5% | Added | Holders |
| Q4 2025 | 390,952 | $5.40M | <0.1% | +324,791+490.9% | Added | Holders |
| Q3 2025 | 66,161 | $1.62M | <0.1% | −123,408−65.1% | Reduced | Holders |
| Q2 2025 | 189,569 | $4.38M | <0.1% | +132,121+230.0% | Added | Holders |
| Q1 2025 | 57,448 | $1.55M | <0.1% | +16,272+39.5% | Added | Holders |
| Q4 2024 | 41,176 | $2.20M | <0.1% | +25,034+155.1% | Added | Holders |
| Q3 2024 | 16,142 | $733.3K | <0.1% | −16,720−50.9% | Reduced | Holders |
| Q2 2024 | 32,862 | $1.38M | <0.1% | −10,289−23.8% | Reduced | Holders |
| Q1 2024 | 43,151 | $1.62M | <0.1% | −18,017−29.5% | Reduced | Holders |
| Q4 2023 | 61,168 | $656.3K | <0.1% | +50,521+474.5% | Added | Holders |
| Q3 2023 | 10,647 | $107.3K | <0.1% | −17,133−61.7% | Reduced | Holders |
| Q2 2023 | 27,780 | $329.7K | <0.1% | +14,613+111.0% | Added | Holders |
| Q1 2023 | 13,167 | $159.3K | <0.1% | +13,167 | New | Holders |